STOCK TITAN

Ouster (OUST) SEC Filings, Jun-Jul 2026

OUST NASDAQ

Ouster, Inc. filings document the public-company record for a Nasdaq-listed sensing and perception company with common stock traded under OUST. The disclosures cover operating results, product revenue commentary, lidar and camera shipment data, and material events tied to its digital lidar, camera vision, AI compute, sensor fusion and perception software portfolio.

Recent filings include Form 8-K reports for financial results, the closed Stereolabs acquisition and an at-the-market common stock sales agreement under a shelf registration statement. Proxy materials describe annual meeting matters, board governance and stockholder voting procedures. Form 25 notices document Nasdaq removal and registration withdrawal for warrant securities, while the company’s cover disclosures identify common stock on the Nasdaq Global Select Market.

Rhea-AI Summary

Ouster, Inc. is offering shares of its common stock pursuant to a shelf preliminary prospectus supplement dated July 2, 2026. The supplement does not state the number of shares or total offering amount. The company notes the last reported sale price was $60.02 per share on July 1, 2026. The prospectus describes an underwriter option to purchase additional shares for 30 days to cover over-allotments and states net proceeds will be used for working capital and general corporate purposes and potentially co-development or acquisitions. As of March 31, 2026, historical net tangible book value was approximately $202.1 million or $3.18 per share, adjusted to $300.1 million or $4.47 per share after a subsequent at-the-market sale of 3,649,000 shares for net proceeds of approximately $98.0 million. The prospectus discloses standard offering mechanics, underwriting discounts, lock-up restrictions, stabilization/market-making practices, and cross-border selling restrictions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.96%
Tags
prospectus
-
Rhea-AI Summary

Ouster, Inc. filed a shelf registration statement to offer and sell common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts and units from time to time after the effective date.

The prospectus states the company may sell securities through underwriters, dealers, agents or directly, and that each offering will be described in a prospectus supplement with amounts, prices and terms. The prospectus discloses corporate details including authorized capital of 200,000,000 common shares and 100,000,000 preferred shares, the acquisition of Stereolabs on February 4, 2026, and the launch of the Rev8 sensor family on May 4, 2026. The document also states the last reported Nasdaq sale price was $62.52 per share as of June 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.96%
Tags
other
-
Rhea-AI Summary

SKAGGS STEPHEN A reported acquisition or exercise transactions in this Form 4 filing.

Ouster, Inc. director Stephen A. Skaggs received a grant of 4,725 shares of common stock in the form of restricted stock units. The RSUs carry no purchase price and will vest in quarterly installments through the earlier of June 17, 2027 or the company’s next annual stockholders’ meeting, contingent on his continued service. Following this award, he directly holds 66,415 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
insider
Rhea-AI Summary

Eyler Phillip reported acquisition or exercise transactions in this Form 4 filing.

Ouster director Phillip Eyler reported receiving a grant of 4,725 shares of common stock as a stock-based award, with no cash paid per share. After this equity grant, his direct holdings increased to 20,383 Ouster shares.

The award consists of Ouster restricted stock units (RSUs), each representing one share of common stock. The RSUs vest in quarterly installments through the earlier of June 17, 2027 or the company’s 2027 annual stockholder meeting, as long as he continues serving the company. All vested RSUs will be settled in shares upon the earlier of a change in control or his separation from service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
insider
-
Rhea-AI Summary

MADDOCK ERNEST E reported acquisition or exercise transactions in this Form 4 filing.

Ouster, Inc. director Ernest E. Maddock received a grant of 4,725 shares of common stock on June 17, 2026, reported as a compensation-related award at no purchase price. Following this grant, his direct holdings increased to 88,902 shares of Ouster common stock.

The award represents restricted stock units, each giving a right to one share of common stock. These units vest in quarterly installments through the earlier of June 17, 2027 or Ouster’s next annual meeting of stockholders, as long as Maddock continues to serve the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
insider
-
Rhea-AI Summary

Ouster director Ted L. Tewksbury III reported both an equity grant and a small share sale. On June 17, 2026, he acquired 4,725 shares of common stock at $0 as a grant tied to restricted stock units that vest quarterly through the earlier of June 17, 2027 or the 2027 annual meeting, subject to continued service. On June 22, 2026, he sold 1,695 shares of common stock at $47.00 per share in an open-market transaction under a pre-arranged Rule 10b5-1 plan that includes tax planning sales. Following these transactions, he directly holds 124,999 shares of Ouster common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
insider
Rhea-AI Summary

Heystee Susan reported acquisition or exercise transactions in this Form 4 filing.

Ouster, Inc. director Susan Heystee reported an equity compensation grant of 4,725 restricted stock units (RSUs) of common stock. Each RSU represents a right to receive one share of Ouster common stock at no purchase price. The RSUs vest in quarterly installments through the earlier of June 17, 2027 or Ouster’s next annual meeting of stockholders, subject to her continued service. Following this grant, Heystee directly holds 39,818.7 shares of common stock, reflecting a routine, compensation-related increase in her equity position rather than an open-market trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
insider
-
Rhea-AI Summary

Correia Christina reported acquisition or exercise transactions in this Form 4 filing.

Ouster, Inc. director Christina Correia received an equity award of 4,725 restricted stock units (RSUs) on common stock. The RSUs vest in quarterly installments through the earlier of June 17, 2027 or Ouster’s next annual stockholder meeting, as long as she continues in service. After this grant, she directly holds 76,415 shares of Ouster common stock, so the award reflects a routine, compensation-related increase rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
insider
-
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
other
Rhea-AI Summary

Ouster, Inc. held its 2026 annual stockholder meeting on June 17, 2026, where shareholders approved an amendment to double the company’s authorized common stock from 100,000,000 to 200,000,000 shares. This change became effective the same day when the certificate of amendment was filed in Delaware.

Two Class II directors, Phillip M. Eyler and Angus Pacala, were elected to serve until the 2029 annual meeting. Stockholders also ratified PricewaterhouseCoopers LLP as auditor for 2026 and approved, on an advisory basis, executive compensation. A proposal to add officer exculpation to the charter did not receive sufficient support.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.38%
Tags
current report

FAQ

How many Ouster (OUST) SEC filings are available on StockTitan?

StockTitan tracks 147 SEC filings for Ouster (OUST), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ouster (OUST)?

The most recent SEC filing for Ouster (OUST) was filed on July 2, 2026.